Functional analysis of a tryptophan-less P-glycoprotein: A tool for tryptophan insertion and fluorescence spectroscopy

Molecular Pharmacology

Volumn 58, Issue 1, 2000, Pages 37-47

  Kwan, Tony ^a   Loughrey, Helen ^b   Brault, Martine ^a   Gruenheid, Samantha ^a   Urbatsch, Ina L ^c   Senior, Alan E ^c   Gros, Philippe ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCEIN; COLCHICINE; DACTINOMYCIN; DOXORUBICIN; GLYCOPROTEIN P; VINBLASTINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; FLUORESCENCE SPECTROSCOPY; GENE OVEREXPRESSION; GENETIC ENGINEERING; MULTIDRUG RESISTANCE; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 0033924206     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.1.37     Document Type: Article

References (40)

1. Azzaria M, Schurr E and Gros P (1989) Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance. Mol Cell Biol 9:5289-5297.
2. Beaudet L and Gros P (1995) Functional dissection of P-glycoprotein nucleotide-binding domains in chimeric and mutant proteins: Modulation of drug resistance profiles. J Biol Chem 270:17159-17170.
3. Brewer CB (1994) Cytomegalovirus plasmid vectors for permanent lines of polarized epithelial cells. Methods Cell Biol 43:233-245.
4. Devault A and Gros P (1990) Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol 10:1652-1663.
5. Devine SE, Ling V and Melera PW (1992) Amino acid substitutions in the sixth transmembrane domain of P-glycoprotein alter multidrug resistance. Proc Natl Acad Sci USA 89:4564-4568.
6. Essodaigui M, Broxterman HJ and Garnier-Suillerot A (1998) Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 37:2243-2250.
7. Greenberger LM (1993) Major photoaffinity drug labeling sites for iodoaryl azido-prazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12. J Biol Chem 268:11417-11425.
8. Gros P, Croop J and Housman D (1986) Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47:371-380.
9. Hafkemeyer P, Dey S, Ambudkar SV, Hrycyna CA, Pastan I and Gottesman MM (1998) Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein. Biochemistry 37: 16400-16409.
10. Hanna M, Brault M, Kwan T, Kast C and Gros P (1996) Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning. Biochemistry 35:3625-3635.
11. Hanna M and Gros P (1996) Cloning and structure: Function analysis of the mouse mdr gene family, in Multidrug Resistance in Cancer Cells: Molecular, Biochemical, Physiological and Biological Aspects (Gupta S and Tsuruo T eds) pp 5-28, John Wiley and Sons, New York.
12. Homolya L, Hollo Z, Germann UA, Pastan I, Gottesman MM and Sarkadi B (1993) Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 268:21493-21496.
13. Kartner N, Evernden-Porelle D, Bradley G and Ling V (1985) Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature (Lond) 316:820-823.
14. Kast C, Canfield V, Levenson R and Gros P (1995) Membrane topology of P-glycoprotein as determined by epitope insertion: Transmembrane organization of the N-terminal domain of mdr3. Biochemistry 34:4402-4411.
15. Kast C, Canfield V, Levenson R and Gros P (1996) Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence. J Biol Chem 271:9240-9248.
16. Lerner-Marmarosh N, Gimi K, Urbatsch IL, Gros P and Senior AE (1999) Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of wild-type, Walker A, and Walker B mutant proteins. J Biol Chem 274:34711-34718.
17. Ling V (1997) Multidrug resistance: Molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40:S3-S8.
18. Liu R and Sharom FJ (1996) Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry 35:11865-11873.
19. Liu R and Sharom FJ (1998) Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: A resonance energy transfer study. Biochemistry 37:6503-6512.
20. Loo TW and Clarke DM (1994) Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein. Biochemistry 33:14049-14057.
21. Loo TW and Clarke DM (1995a) Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity. J Biol Chem 270:22957-22961.
22. Loo TW and Clarke DM (1995b) Membrane topology of a cysteine-less mutant of human P-glycoprotein. J Biol Chem 270:843-848.
23. Loo TW and Clarke DM (1996) Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates. J Biol Chem 271:27482-27487.
24. Loo TW and Clarke DM (1997a) Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12. J Biol Chem 272:20986-20989.
25. Loo TW and Clarke DM (1997b) Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate. J Biol Chem 272:31945-31948.
26. Raymond M, Gros P, Whiteway M and Thomas DY (1992) Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene. Science (Wash DC) 256:232-234.
27. Raymond M, Ruetz S, Thomas DY and Gros P (1994) Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosuppressive and antifungal agent FK520. Mol Cell Biol 14:277-286.
28. Rosenberg MF, Callaghan R, Ford RC and Higgins CF (1997) Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J Biol Chem 272:10685-10694.
29. Ruetz S and Gros P (1994) Phosphatidylcholine translocase: A physiological role for the mdr2 gene. Cell 77:1071-1081.
30. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP, Berns AJM and Borst P (1994) Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
31. Senior AE (1998) Catalytic mechanism of P-glycoprotein. Acta Physiol Scand Suppl 643:213-218.
32. Shapiro AB and Ling V (1998) The mechanism of ATP-dependent multidrug transport by P-glycoprotein. Acta Physiol Scand Suppl 643:227-234.
33. Tang-Wai DF, Brossi A, Arnold LD and Gros P (1993) The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance. Biochemistry 32:6470-6476.
34. Urbatsch IL, Beaudet L, Carrier I and Gros P (1998) Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites. Biochemistry 37:4592-4602.
35. Vanhelvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P and Vanmeer G (1996) mdr1 P-glycoprotein is a lipid translocase of broad specificity, while mdr3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87:507-517.
36. Vernet T, Dignard D and Thomas DY (1987) A family of yeast expression vectors containing the phage f1 intergenic region. Gene 52:225-233.
37. Wang Q, Matsushita K, de Foresta B, le Maire M and Kaback HR (1997) Ligand-induced movement of helix X in the lactose permease from Escherichia coli: A fluorescence quenching study. Biochemistry 36:14120-14127.
38. Weber J, Wilke-Mounts S, Hammond ST and Senior AE (1998) Tryptophan substitutions surrounding the nucleotide in catalytic sites of F1-ATPase. Biochemistry 37:12042-12050.
39. Yoshimura A, Kuwazuru Y, Sumizawa T, Ichikawa M, Ikeda S, Uda T and Akiyama S (1989) Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. J Biol Chem 264:16282-16291.
40. Zhou T and Rosen BP (1997) Tryptophan fluorescence reports nucleotide-induced conformational changes in a domain of the ArsA ATPase. J Biol Chem 272:19731-19737.